Author:
Remschmidt Cornelius,Wichmann Ole,Harder Thomas
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Anand S, Bitton A, Gaziano T: The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One. 2013, 8: e72860-10.1371/journal.pone.0072860.
2. U.S. Renal Data System: USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013.
3. White SL, Chadban SJ, Jan S, Chapman JR, Cass A: How can we achieve global equity in provision of renal replacement therapy?. Bull World Health Organ. 2008, 86: 229-237. 10.2471/BLT.07.041715.
4. Descamps-Latscha B: The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens. 1993, 2: 883-891. 10.1097/00041552-199311000-00005.
5. Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R: Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008, 28: S183-S187.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献